Browsing Tag
Teva Pharmaceutical Industries Limited
2 posts
Teva gets Priority Review for ecopipam just months after buying Emalex for $700m
Teva has secured FDA Priority Review for ecopipam in pediatric Tourette syndrome, putting a late first-quarter 2027 decision date on the key asset acquired through its $700 million purchase of Emalex Biosciences.
Natco Pharma completes full US generic Revlimid lineup with new lenalidomide strengths
Natco Pharma and Teva Pharmaceuticals launch 2.5 mg and 20 mg generic lenalidomide in US, completing their Revlimid portfolio for multiple myeloma treatment.